Colesevelam curbs glucose concentration in study

01/31/2013 | PhysiciansBriefing.com

Colesevelam therapy was associated with lower fasting and postprandial glucose concentrations in type 2 diabetes patients on metformin monotherapy, a study in Diabetes found. Researchers also discovered colesevelam did not affect insulin concentration, secretion or action in patients.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA